Inventor · disambiguated record
Thomas Grunwald
Also filed as: GRUNWALD THOMAS · GRUNWALD THOMAS LUDWIG
12 granted patents·13 pending applications·32 citations·filing 1974–2022
86Inventor score
Top patents by PatentIndex Score
25 records- 0185US7897153B1Chimera of human IgE receptor α-chain and avian constant immuno-globulin domains for the determination of serum IgEPLS DESIGN GMBH·Filed 2006·Granted Mar 1, 2011·13 cites·19 claims
- 0279US10238735B2Controlled activation of complement components for use as endogenous adjuvantPLS DESIGN GMBH·Filed 2013·Granted Mar 26, 2019·3 cites·15 claims
- 0370US8372963B2RSV F-protein and its usePEVION BIOTECH AG·Filed 2007·Granted Feb 12, 2013·3 cites·16 claims
- 0468US7696323B2Bivalent IgY antibody constructs for diagnostic and therapeutic applicationsPLS DESIGN GMBH·Filed 2006·Granted Apr 13, 2010·1 cites·23 claims
- 0567US2022273791A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationBREDEHORST REINHARD·Filed 2021·Application pending·0 cites
- 0657US2014163200A1Method for determining an unknown PNA sequence and uses thereofPLS DESIGN GMBH·Filed 2013·Application pending·0 cites
- 0755US2014178474A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationPLS DESIGN GMBH·Filed 2013·Application pending·0 cites
- 0854US2025057802A1Broad-spectrum antiviral drugsFRAUNHOFER GES FORSCHUNG·Filed 2022·Application pending·0 cites
- 0952US9446121B2Cloning of honey bee allergenGRUNWALD THOMAS·Filed 2009·Granted Sep 20, 2016·0 cites·14 claims
- 1052US2010081801A1Method for determining an unknown PNA sequence and uses thereofRINA NETZWERK RNA TECHNOLOGIEN·Filed 2006·Application pending·0 cites
- 1152US2018117143A1Pharmaceutical composition for treatment of allergic reactionsPLS DESIGN GMBH·Filed 2017·Application pending·0 cites
- 1252US2019282692A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationBREDEHORST REINHARD·Filed 2018·Application pending·0 cites
- 1352US2014335162A1Pharmaceutical composition for treatment of allergic reactionsPLS DESIGN GMBH·Filed 2012·Application pending·0 cites
- 1450US7846690B2Cloning of honey bee allergenPLS DESIGN GMBH·Filed 2005·Granted Dec 7, 2010·0 cites·23 claims
- 1549US11946048B2Non-human papillomaviruses for gene delivery in vitro and in vivoFRAUNHOFER GES FORSCHUNG·Filed 2018·Granted Apr 2, 2024·0 cites·6 claims
- 1647US2016271257A1Low Molecular Weight Immune-Modulators As Adjuvants for Specific ImmunotherapyPLS-DESIGN GMBH·Filed 2014·Application pending·0 cites
- 1747US2017072048A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationPLS-DESIGN GMBH·Filed 2015·Application pending·0 cites
- 1845US2013337044A1Modulation of effector t cell responses by local depletion of complement component c3PLS DESIGN GMBH·Filed 2013·Application pending·0 cites
- 1944US7888068B2Cloning of honey bee allergen CPLS DESIGN GMBH·Filed 2007·Granted Feb 15, 2011·0 cites·16 claims
- 2041US2016338955A1Antigen-specific immunotherapy using tolerizing liposomesPLS-DESIGN GMBH·Filed 2016·Application pending·0 cites
- 2138US11065330B2Induction of antigen-specific tolerance by peripheral phagocytosisPLS DESIGN GMBH·Filed 2015·Granted Jul 20, 2021·0 cites·6 claims
- 2237US3982582AMethod and apparatus for casting metals into a continuous casting moldCONCAST AG·Filed 1974·Granted Sep 28, 1976·8 cites·14 claims
- 2335US2018085452A1Matrix-embedded tolerance-promoting adjuvants for subcutaneous immunotherapyTOLEROGENICS S A R L·Filed 2017·Application pending·0 cites
- 2434US8802836B2Cloning and recombinant productions of Vespula venom protease and methods of use thereofSEISMANN HENNING·Filed 2010·Granted Aug 12, 2014·0 cites·8 claims
- 2534US5714344AProtease-derivatized CVFUNIV GEORGETOWN·Filed 1993·Granted Feb 3, 1998·4 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Grunwald files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →